# | Title | Journal | Year | Citations |
---|
|
1 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 4,789 |
2 | Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data | Lancet Oncology, The | 2014 | 717 |
3 | Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells | Blood | 2001 | 443 |
4 | Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document | Radiotherapy and Oncology | 2020 | 405 |
5 | VHL and HIF signalling in renal cell carcinogenesis | Journal of Pathology | 2010 | 265 |
6 | The potential and controversy of targeting STAT family members in cancer | Seminars in Cancer Biology | 2020 | 253 |
7 | Comparative Analysis of Dynamic Cell Viability, Migration and Invasion Assessments by Novel Real-Time Technology and Classic Endpoint Assays | PLoS ONE | 2012 | 232 |
8 | Single-Cell RNA Sequencing Maps Endothelial Metabolic Plasticity in Pathological Angiogenesis | Cell Metabolism | 2020 | 196 |
9 | Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients | BMC Immunology | 2010 | 191 |
10 | Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic | Breast | 2020 | 191 |
11 | Long-term sequelae in children after cerebellar astrocytoma surgery | Neurology | 2004 | 186 |
12 | Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial | Lancet Oncology, The | 2020 | 182 |
13 | Differences in human papillomavirus type distribution in high‐grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe | International Journal of Cancer | 2013 | 180 |
14 | Overview of artificial intelligence-based applications in radiotherapy: Recommendations for implementation and quality assurance | Radiotherapy and Oncology | 2020 | 173 |
15 | A Comparison of Cell-Free DNA Isolation Kits | Journal of Molecular Diagnostics | 2017 | 172 |
16 | Programmed Cell Death-1 Inhibitor–Induced Type 1 Diabetes Mellitus | Journal of Clinical Endocrinology and Metabolism | 2018 | 171 |
17 | Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer | British Journal of Cancer | 2010 | 168 |
18 | Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting | British Journal of Cancer | 2013 | 148 |
19 | European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer | Lancet Oncology, The | 2022 | 143 |
20 | Pituitary Progenitor Cells Tracked Down by Side Population Dissection | Stem Cells | 2009 | 141 |
21 | A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy | Oncologist | 2010 | 139 |
22 | Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer | British Journal of Cancer | 1999 | 138 |
23 | Combined Modality Therapy of Gemcitabine and Radiation | Oncologist | 2005 | 135 |
24 | Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data | Oncologist | 2017 | 133 |
25 | Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials | Lancet Haematology,the | 2015 | 131 |
26 | Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients | Lung Cancer | 2017 | 131 |
27 | Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib | Clinical Pharmacology and Therapeutics | 2006 | 127 |
28 | Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype | British Journal of Cancer | 2010 | 127 |
29 | TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer | Clinical Cancer Research | 2019 | 127 |
30 | Review: Implications of In Vitro Research on the Effect of Radiotherapy and Chemotherapy Under Hypoxic Conditions | Oncologist | 2007 | 126 |
31 | Human papillomavirus prevalence and type‐distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study | International Journal of Cancer | 2015 | 126 |
32 | Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies | Cancer Chemotherapy and Pharmacology | 2003 | 125 |
33 | Curcumin inhibitsin vitroandin vivochronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21 | Oncotarget | 2015 | 113 |
34 | The influence of a pneumoperitoneum on the peritoneal implantation of free intraperitoneal colon cancer cells | Surgical Endoscopy and Other Interventional Techniques | 1996 | 109 |
35 | Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns | European Urology | 2017 | 109 |
36 | Ultrafiltration and size exclusion chromatography combined with asymmetrical‐flow field‐flow fractionation for the isolation and characterisation of extracellular vesicles from urine | Journal of Extracellular Vesicles | 2018 | 109 |
37 | Cognitive Deficits and Predictors 3 Years After Diagnosis of a Pilocytic Astrocytoma in Childhood | Journal of Clinical Oncology | 2009 | 108 |
38 | Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy | European Urology | 2019 | 108 |
39 | The HILUS-Trial—a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy | Journal of Thoracic Oncology | 2021 | 108 |
40 | Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling | Breast Cancer Research and Treatment | 2006 | 107 |
41 | Generation of Merkel Cell Polyomavirus (MCV)-Like Particles and Their Application to Detection of MCV Antibodies | Journal of Clinical Microbiology | 2010 | 107 |
42 | Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas | Annals of Oncology | 1995 | 93 |
43 | Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI | Cancer Microenvironment | 2011 | 91 |
44 | The interaction between ER and NFκB in resistance to endocrine therapy | Breast Cancer Research | 2012 | 90 |
45 | Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer | Breast Cancer Research and Treatment | 2006 | 87 |
46 | NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation | British Journal of Cancer | 2007 | 87 |
47 | Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix | Best Practice and Research in Clinical Obstetrics and Gynaecology | 2005 | 85 |
48 | Anti-Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance | Oncologist | 2013 | 85 |
49 | Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor | Medicinal Research Reviews | 2016 | 83 |
50 | Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment | ESMO Open | 2021 | 81 |